tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Everest Medicines Ltd.
HK$51.50
HK$16.55B
-22.81
-0.60%
0 Buy
1 Hold
0 Sell
Hold
InnoCare Pharma Ltd.
HK$13.30
HK$19.85B
-94.19
118.39%
5 Buy
1 Hold
0 Sell
Strong Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.28
HK$9.81B
-47.25
62.20%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$15.06B
-53.18
61.42%
4 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.54
HK$8.60B
-14.62
58.04%
0 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$10.49B
13.74
-3.34%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1952
Everest Medicines Ltd.
50.00
0.30
0.60%
HK:9969
InnoCare Pharma Ltd.
13.30
7.21
118.39%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.32
2.04
62.20%
HK:2162
Keymed Biosciences, Inc.
54.40
20.75
61.66%
HK:2171
CARsgen Therapeutics Holdings Ltd.
14.54
5.66
63.74%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
24.90
-1.29
-4.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts